Status:
COMPLETED
Changing of Trace Element, Homocysteine, Oxidative Stress Parameters and Physical Activity Levels in Covid-19
Lead Sponsor:
Izmir Bakircay University
Collaborating Sponsors:
Cigli Regional Training Hospital
Muğla Sıtkı Koçman University
Conditions:
Covid19
Eligibility:
All Genders
35-65 years
Brief Summary
With the rapid spread of COVID-19 (SARS-CoV-2) disease all over the world and the announcement of a pandemic, researches on many different drug approaches have begun and these researches continue toda...
Detailed Description
Since December 2019, the new severe acute respiratory syndrome coronavirus 2, called SARS-CoV-2, has spread rapidly to almost every country that causes coronavirus disease-19 (COVID-19) pneumonia. Cur...
Eligibility Criteria
Inclusion
- To agree to participate in the study voluntarily,
- Having a diagnosis of COVID-19,
Exclusion
- Having been taking trace element supplements for the last 2 weeks and/or currently,
- Patients who do not need hospitalization,
- Having a diagnosis of kidney failure and/or heart failure,
- Being pregnant,
- Body mass index over 40 kg/m2
Key Trial Info
Start Date :
January 6 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 29 2021
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT04694703
Start Date
January 6 2021
End Date
August 29 2021
Last Update
September 16 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kadirhan Ozdemir
Izmir, Turkey (Türkiye), 06580